Jiawang Wu , Yi Fu , Xiaolan Wang , Ting Liu , Xinting Zhang , Chongchang Qu , Qianyue Zhang , Shuanglan Xu , Jiao Yang , Xiqian Xing
{"title":"Revealing immune cell secretion crosstalk in pulmonary pathogenesis: A microfluidic lung-on-a-chip approach","authors":"Jiawang Wu , Yi Fu , Xiaolan Wang , Ting Liu , Xinting Zhang , Chongchang Qu , Qianyue Zhang , Shuanglan Xu , Jiao Yang , Xiqian Xing","doi":"10.1016/j.ijpharm.2025.126203","DOIUrl":null,"url":null,"abstract":"<div><div>As a highly biomimetic in vitro microfluidic technology, the Lung-on-a-Chip (LOC) is capable of precisely simulating the pulmonary microenvironment and physiological functions, thereby providing an essential tool for the study of pulmonary diseases. The LOC constructs alveolar, airway, and vascular structures through multi-layered channels and biomaterials, supporting the culture of various types of cells. Its microstructural design can mimic the mechanical stimuli of respiratory movements, thereby influencing cellular behavior. Immune cells and their secreted cytokines play a crucial role in maintaining pulmonary homeostasis, and the LOC model offers a unique perspective for studying the behavioral characteristics of immune cells, their signaling pathways, and their synergistic interactions with other cells. This review focuses on the in-depth investigation of the mechanisms underlying the role of immune cells and their secretory products in pulmonary diseases using LOC technology, with the aim of providing theoretical foundations and innovative ideas for the development of therapeutic strategies and targets for pulmonary diseases. In the future, LOC technology is expected to advance the treatment and drug development for respiratory diseases through personalized medicine, multi-organ-on-a-chip systems, and interdisciplinary collaborations.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"685 ","pages":"Article 126203"},"PeriodicalIF":5.2000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325010403","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
As a highly biomimetic in vitro microfluidic technology, the Lung-on-a-Chip (LOC) is capable of precisely simulating the pulmonary microenvironment and physiological functions, thereby providing an essential tool for the study of pulmonary diseases. The LOC constructs alveolar, airway, and vascular structures through multi-layered channels and biomaterials, supporting the culture of various types of cells. Its microstructural design can mimic the mechanical stimuli of respiratory movements, thereby influencing cellular behavior. Immune cells and their secreted cytokines play a crucial role in maintaining pulmonary homeostasis, and the LOC model offers a unique perspective for studying the behavioral characteristics of immune cells, their signaling pathways, and their synergistic interactions with other cells. This review focuses on the in-depth investigation of the mechanisms underlying the role of immune cells and their secretory products in pulmonary diseases using LOC technology, with the aim of providing theoretical foundations and innovative ideas for the development of therapeutic strategies and targets for pulmonary diseases. In the future, LOC technology is expected to advance the treatment and drug development for respiratory diseases through personalized medicine, multi-organ-on-a-chip systems, and interdisciplinary collaborations.
期刊介绍:
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.